Patent Term Application for BRINSUPRI® (brensocatib), Patent No. 9,522,894 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-5206

Patent Term Application for BRINSUPRI® (brensocatib), Patent No. 9,522,894

Documents

Comments

Description

OPEN

Comment Period OpensOct 16, 2025

Type	Title	Posted	Comments	Status
Other	Letter from U.S Patent and Trademark Office to FDA CDER	Mar 25, 2026	--

CDER

Patent Term Application

Cooley LLP

Insmed Incorporated

BRINSUPRI (brensocatib)

Patent No. 9,522,894

OPEN